WHO calls for research scale-up towards ending TB in South-East Asia region
Experts, national TB programme managers and researchers along with partners and members of civil society began a three-day virtual workshop organised by the World Health Organization (WHO) for advancing research and innovation to accelerate momentum towards ending TB in the WHO South-East Asia region.
'In our Region alone, nearly 5 million people developed TB and close to 600,000 died from the disease in 2023," said Dr Catharina Boehme, Officer-in-Charge, WHO South-East Asia Region.
Calling for urgent action, she said that achieving the ambitious targets in the WHO End TB Strategy requires collaboration to accelerate research and innovation.
It requires the adoption and use of new tools, technologies and drugs. Ensuring timely and equitable access to these innovations remains critical to achieving impacts at scale, leaving no one behind, Boehme said.
While the region recorded a significant increase in TB case notifications in 2023, signalling recovery after COVID-19-related setbacks, progress remains insufficient to meet the End TB Strategy targets aligned with the sustainable development goals that call for a 90 per cent reduction in TB deaths and an 80 per cent reduction in incidence by 2030 compared to 2015 levels.
Post-COVID-19 pandemic, TB once again reemerged as the world's leading cause of death from a single infectious agent, the WHO said in a statement.
It places a disproportionate burden on the poorest and most vulnerable, further exacerbating inequalities.
In the South-East Asia region, 30 per cent to 80 per cent of the TB-affected households experience catastrophic costs, underscoring the need for equitable, people-centred approaches and strengthening social protection for the affected, the statement said.
Despite these challenges, the WHO South-East Asia region made notable progress. In 2023, 3.8 million new and relapse TB cases were notified, with an 89 per cent treatment success rate for those who began treatment in 2022. Missed cases dropped to 22 per cent in 2023, down from 44 per cent in 2020, the statement said.
Backed by strong political commitment, countries in the region are increasingly leveraging new approaches such as artificial intelligence for case detection, computer-aided diagnostics, digital adherence tools and direct benefit transfers for patients, streamlining the social support process.
At the same time, several countries are undertaking important research, including epidemiological research to assess the disease burden, the statement said.
Bangladesh recently completed a patient cost survey, while findings from India's RATIONS study on the impact of nutrition on TB outcomes and incidence of the disease have contributed to the global guidance.
Social and community-based innovations are also playing a vital role. Nepal's TB-Free Pallika initiative and multisectoral coordination mechanisms in Myanmar are helping reach vulnerable populations with person-centred care.
A review by the WHO South-East Asia found that member states published over 3,000 TB-related research articles in the past six years, with 60 per cent being original research. However, uptake of research outcomes remains uneven due to knowledge gaps and limited platforms for knowledge exchange and collaborative use, the statement said.
'Our progress is uneven. Research and innovation capacity is varied across the Region, and the results of these efforts are often siloed and unavailable for collaborative use. The rise in drug-resistant forms of TB remains very concerning," said Dr Boehme.
The key areas of focus during the virtual consultation include strengthening of South-South collaboration, vaccine preparedness, digital tools for patient care and adherence and efforts to overcome vaccine hesitancy.
Participants will also discuss aligning regulatory processes, promoting data sharing and improving platforms for knowledge exchange. A significant emphasis is being placed on identifying operational implementation research priorities, especially in relation to social determinants such as undernutrition and climate change, which influence TB incidence and outcomes.
top videos
View all
'Several ongoing innovations are attempting to reach out to marginalized and vulnerable groups through active case finding and providing affected families socio-economic support to mitigate catastrophic costs", said Dr Boehme.
Highlighting the importance of equity, she added, 'It is incumbent to ensure equitable access to the benefits of research and innovation, including vaccines, medicines and diagnostics." PTI PLB KSS KSS
(This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments
First Published:
August 05, 2025, 19:30 IST
News agency-feeds WHO calls for research scale-up towards ending TB in South-East Asia region
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
24 minutes ago
- Time of India
CDC issues level 2 travel alert for China as chikungunya spreads — Symptoms US travelers should watch for
Americans planning a trip to China are being urged to stay alert. The U.S. Centers for Disease Control and Prevention (CDC) has issued a Level 2 travel alert following a major outbreak of the chikungunya virus. The warning comes after over 7,000 cases were reported in Guangdong province, according to the BBC. In Foshan, one of the hardest-hit cities, patients are being hospitalized until they test negative. Hospitals are using mosquito nets on beds, something not seen since the early COVID-19 days. How the virus spreads Chikungunya is a mosquito-borne virus. It spreads through the bite of an infected female mosquito—usually Aedes aegypti or Aedes albopictus. These mosquitoes also transmit dengue and Zika. They bite mostly during daylight and lay eggs in still water, like puddles, buckets, or plant pots. When a mosquito bites someone infected with chikungunya, it picks up the virus. Over the next few days, the virus multiplies inside the mosquito. Once it reaches the mosquito's saliva, it can pass on the virus to the next person it bites. That person can then pass it on to more mosquitoes, creating a cycle. Symptoms to watch for As per the World Health Organization, Symptoms usually appear 4–8 days after the bite (but can show up as early as 2 days or as late as 12). The illness often begins suddenly. Key signs include: High fever Intense joint pain (often severe and long-lasting) Swollen joints Muscle pain Headache Nausea Fatigue Rash Symptoms can be confused with other viruses like dengue and Zika. Without the telltale joint pain, mild cases may go unnoticed. Patients mostly recover fully from the infection; however, occasional cases of eye, heart, and neurological complications have been reported with CHIKV infections. Who is at risk? Those at highest risk for severe chikungunya infection include people at the extremes of age. Newborns are particularly vulnerable, especially if they are infected during delivery from a mother who has the virus, or if they are bitten by an infected mosquito within the first few weeks of life. Older adults, particularly those with underlying medical conditions such as heart disease, diabetes, or weak immunity, are also more likely to experience complications. How to protect yourself? If you are travelling to China or places nearby, it is advised to follow some precautions to protect yourself Apply EPA-registered insect repellents containing DEET, picaridin, or oil of lemon eucalyptus to exposed skin to prevent bites. Covering your skin reduces the chances of mosquitoes landing on and biting you. Mosquitoes breed in stagnant water, so steer clear of places with puddles, open containers, or clogged drains. Aedes mosquitoes that spread chikungunya bite mostly during the day, so limit outdoor activity during daylight hours. Proper ventilation and screened windows keep mosquitoes out and help create a safe, bite-free environment indoors.
Time of India
33 minutes ago
- Time of India
Polio lost, but fake records & imperfect vax helped it rear its ugly head
Karachi: For the past decade, Sughra Ayaz has traveled door to door in southeastern Pakistan, pleading with parents to allow children to be vaccinated against polio as part of a global campaign to wipe out the paralytic disease. She hears their demands and fears. Some are practical - families need basics like food and water more than vaccines. Others are simply unfounded - the oral doses are meant to sterilize their kids. Amid rampant misinformation and immense pressure for the campaign to succeed, Ayaz said, some managers have instructed workers to falsely mark children as immunized. And the vaccines, which must be kept cold, aren't always stored correctly, she added. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program "In many places, our work is not done with honesty," Ayaz said. The World Health Organization and partners embarked on their polio campaign in 1988 with the bold goal of eradication - a feat seen only once for human diseases, with smallpox in 1980. They came close several times, including in 2021, when just five cases of the natural virus were reported in Pakistan and Afghanistan. But since then, cases rebounded, hitting 99 last year, and officials have missed at least six self-imposed eradication deadlines. Afghanistan and Pakistan remain the only countries where transmission of polio - which is highly infectious, affects mainly children under 5, and can cause irreversible paralysis within hours -- has never been interrupted. The worldwide campaign has focused most of its attention and funding there for the past decade. But in its quest to eliminate the disease, the Global Polio Eradication Initiative has been derailed by mismanagement and what insiders describe as blind allegiance to an outdated strategy and a problematic oral vaccine, according to workers, polio experts and internal materials. Live Events Officials have falsified vaccination records, selected unqualified people to dole out drops, failed to send out teams during mass campaigns, and dismissed concerns about the oral vaccine sparking outbreaks, according to documents shared with AP by staffers from GPEI - one of the largest and most expensive public health campaigns in history, with over $20 billion spent and nearly every country in the world involved. In Afghanistan and Pakistan - which share a border, harbor widespread mistrust of vaccines, and have weakened healthcare systems and infrastructure - local staffers like Ayaz have for years flagged problems to senior managers. But those issues, along with concerns by staffers and outside health officials, have long gone unaddressed, insiders say. Officials tout the successes - 3 billion children vaccinated, an estimated 20 million people who would have been paralyzed spared - while acknowledging challenges in Pakistan and Afghanistan. Remote villages are hard to reach, some cultural and religious authorities instruct against vaccination, and hundreds of polio workers and security staff have been killed because of their alignment with a Western-led initiative. Dr. Jamal Ahmed, WHO's polio director, defended progress in those two countries. "There's so many children being protected today because of the work that was done over the past 40 years," he said. "Let's not overdramatize the challenges, because that leads to children getting paralyzed."
NDTV
an hour ago
- NDTV
China Reports 7,000 Chikungunya Cases; Know Symptoms, Cause And Treatment
China is a facing a major chikungunya outbreak with over 7,000 cases of the mosquito-borne virus reported in the Guangdong province. The outbreak has prompted the authorities to trigger actions similar to the COVID-19 outbreak. Among the worst-affected regions in the country is the city of Foshan, where chikungunya patients have been ordered to stay in the hospital until they test negative. In a public notice issued on Sunday (Aug 3), the retail pharmacies have been ordered to start real-name registration and to keep records when selling medications to treat symptoms of chikungunya, including fever, rashes and joint pain. People who have travelled from chikungunya-affected cities in Guangdong have been told to self-monitor for symptoms, according to a report in South China Morning Post. Some hotels and restaurants that failed to promptly eliminate mosquito breeding sites have already been penalised by the authorities. At least 12 other cities apart from Foshan have also reported infections, with nearly 3,000 cases reported last week alone. Meanwhile, Hong Kong reported its first imported chikungunya fever case in six years on Saturday last week, raising the risk of local transmissions in the city. Authorities have been told to step up efforts to fight a potential outbreak. Data has shown that "breeding of the pest that can transmit chikungunya fever is 'fairly extensive' in 70 per cent of the city's surveyed areas". What is chikungunya? Chikungunya is a viral disease transmitted to humans primarily through the bite of infected mosquitoes, mainly Aedes aegypti and Aedes albopictus. Humid weather during the rainy season creates ideal conditions for mosquito breeding. Despite being uncommon in China, Chikungunya epidemics are frequent in South and Southeast Asia as well as some regions of Africa. Symptoms of chikungunya: One of the major symptoms of chikungunya is intense joint pain and stiffness, affecting the hands, wrists, ankles and knees. This kind of joint discomfort is much more severe compared to typical viral infections and is a key distinguishing sign. Apart from joint pain, muscle pain, fatigue and overall weakness are also common in chikungunya. Many chikungunya patients develop a red, patchy rash on the torso, limbs, or face. Most people develop these symptoms within three to seven days of getting bitten. Chikungunya treatment There is no specific chikungunya treatment, but doctors focus on managing symptoms. Treatment for symptoms can include rest, fluids, and the use of analgesics and antipyretics. Nonsteroidal anti-inflammatory drugs can be used to help with acute fever and pain.
